Clinical trial
Randomized Pilot Study Evaluating Effectiveness of Botulinum Toxin Type A in Freezing Walking in Parkinson's Disease
NCT06094309 is registered in ClinicalTrials.gov with Centro Hospitalar de Lisboa Central as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Pilot Study Evaluating Effectiveness of Botulinum Toxin Type A in Freezing Walking in Parkinson's Disease
- Lead sponsor
- Centro Hospitalar de Lisboa Central
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2024
- Completion date
- June 30, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
botulinum toxin, freezing of gate, parkinson disease